Status:
COMPLETED
Prevention of Postoperative Urinary Retention With Treatment of Tamsulosin 5 Days Prior to Lower Limb Arthroplasty
Lead Sponsor:
Kantonsspital Graubünden
Conditions:
Urinary Retention Postoperative
Arthropathy of Knee
Eligibility:
MALE
18+ years
Phase:
PHASE4
Brief Summary
Various studies have shown that the risk of suffering a urinary retention after knee or hip prosthesis surgery is 10-80%. The aim of the study is to reduce this riks. For this purpose, it is investiga...
Detailed Description
Study Category and rationale: This study uses a well-known drug (tamsulosin) which is authorised in Switzerland and widely used to treat obstructive voiding problems. In our case the indication is di...
Eligibility Criteria
Inclusion
- \- male adults undergoing elective hip- or knee arthroplasty
Exclusion
- women
- underage patients
- pre-existing treatment with tamsulosin or other prostate affecting medication
- patients who underwent transurethral resection of the prostate or prostatectomy
- patients with urethral strictures
- patients with neurological bladder dysfunction
- Known allergy to tamsulosin
- Hypotensive disorder
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 4 2025
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT03808155
Start Date
August 1 2019
End Date
March 4 2025
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kantonsspital Graubünden
Chur, Kanton Graubünden, Switzerland, 7000